Senior Director, Vaccine Value Evidence
GSK, Belgium
Disclosure(s): GSK: employee, Stocks/Bonds (Public Company)
Desmond Curran is currently employed as Senior Director, Vaccines Global Value Evidence and Outcomes Portfolio Lead at GlaxoSmithKline. He has more than 20 years’ experience in medical research having worked in a non-profit research organization (European Organisation for Research and Treatment of Cancer (EORTC)), a contract research organization (ICON Clinical Research), and for a pharmaceutical company (GlaxoSmithKline). Desmond completed his PhD in patient reported outcomes while working at the EORTC. He has authored approximately 100 peer reviewed published manuscripts, contributed book chapters in topics such as patient reported outcomes (PROs) and cancer research. Desmond led the GSK vaccines value evidence team supporting the launch of Shingrix, the recombinant zoster vaccine. Desmond’s key areas of expertise include: health economics; patient reported outcomes; value demonstration; real world evidence; pricing & market access; health technology assessment; biostatistics and clinical trial design.